Hughes Financial Services’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.04K Buy
72
+12
+20% +$621 ﹤0.01% 513
2026
Q1
$3.05K Hold
60
– – ﹤0.01% 510
2025
Q4
$1.77K Hold
60
– – ﹤0.01% 585
2025
Q3
$1.49K Sell
60
-39
-39% -$1.09K ﹤0.01% 623
2025
Q2
$2.64K Buy
99
+42
+74% +$1.11K ﹤0.01% 498
2025
Q1
$1.55K Buy
+57
New +$2.02K ﹤0.01% 626

Other funds holding MRNA

Hughes Financial Services's MRNA Position: Q2 2026 in Review

Hughes Financial Services increased its Moderna (MRNA) stake by 20% in Q2 2026, buying an estimated $621 and bringing the position to 72 shares worth $5.04K. The position accounts for ﹤0.01% of the portfolio, ranked #513.

Hughes Financial Services first reported a position in MRNA in Q1 2025 and has held it in 6 quarters since. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Hughes Financial Services held 72 shares of Moderna worth $5.04K as of Q2 2026.
  • Hughes Financial Services bought 12 Moderna shares in Q2 2026, an estimated $621.
  • Moderna made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #513 holding.
  • Hughes Financial Services first reported a position in Moderna in Q1 2025 and has held it in 6 quarters since.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.